Nasdaq
Block listing Interim Review
01-10-2018
BLOCK LISTING SIX MONTHLY RETURN
(Note: Italicised terms have the same meaning as given in the Listing Rules.)
Date: 01 October 2018
| Name of applicant: | Summit Therapeutics plc | |||
| Name of scheme: | 2005 EMI Scheme | |||
| Period of return: | From: | 06 Apr 2018 | To: | 30 Sep 2018 |
| Balance of unallotted securities under scheme(s) from previous return: | 4,451,274 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | Zero | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 48,981 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 4,402,293 | |||
| Name of applicant: | Summit Therapeutics plc | |||
| Name of scheme: | 2016 Long term Incentive Plan | |||
| Period of return: | From: | 06 Apr 2018 | To: | 30 Sep 2018 |
| Balance of unallotted securities under scheme(s) from previous return: | 4,235,713 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | Zero | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 38,850 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 4,196,863 | |||
| Name of contact: | Richard Pye |
| Telephone number of contact: | +44 (0)1235 443951 |